Opendata, web and dolomites

H2020 projects about "fibrosis"

The page lists 85 projects related to the topic "fibrosis".

# achronym  title  year 
1 PRO-CF-MED Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication 2015
2 METASPACE Bioinformatics for spatial metabolomics 2015
3 EPoS Elucidating Pathways of Steatohepatitis 2015
4 BETA3_LVH A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease 2015
5 BREATHE Biochemically modified messenger RNA encoding nucleases for in vivo gene correction of severe inherited lung diseases 2015
6 MyCyFAPP Innovative approach for self-management and social welfare of Cystic Fibrosis patients in Europe: development, validation and implementation of a telematics tool. 2015
7 GLYCO-TOOLS Bio-Inspired Tools for Glycoscience 2015
8 ENABLE Establishment of a Neutrophil elastase Activity home test for the Better management and treatment of Lung Exacerbations 2014
9 GelSwimming Bacterial motion in polymer solutions and biogels 2016
10 CARDI-ACHE The cardiovascular consequences of endurance exercise 2015
11 COMMANDEER COMMANDEER: Disrupting microbial resistance using rationally designed signalling molecules 2015
12 GDA in staphylococci Gen Duplication and Amplification in Staphylococcal populations 2016
13 TARGEPILIVER Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. 2015
14 REZONABLE Regeneration and zonation by ZEB2 of Liver Endothelium 2016
15 AFIBROTIC Atrial Fibrillation, Fibrosis and Rotors: New Insights from Imaging and Computational Modeling 2015
16 Subpopulations Investigating Fibrotic and Regenerative Fibroblast Populations in Muscular Dystrophy 2016
17 FiBRO Fibroblasts in the Biology of Rectal Cancer Progression 2016
18 InCisive creTRAP for in situ Characterization of Fibrosis-Promoting Pathways in Non-alcoholic Fatty Liver Disease 2016
19 2-NanoSi Ratiometric FRET Based Nanosensors for Trypsin Related Human Recessive Diseases 2015
20 HBV1 Innate immune responses to human hepatotropic viral infections 2015
21 PULTAR Delivery of PULmonary Therapeutics through TARgetted Delivery using Phononics 2015
22 STARS Strategies Targeting Thyroid Hormone in Athrophy Related Syndromes 2015
23 PERIF Perivascular cells at the crossroads of inflammation, regeneration and fibrosis 2015
24 HEPCIR Cell circuits as targets and biomarkers for liver disease and cancer prevention 2016
25 TAT-CF Novel therapeutic approaches for the treatment of cystic fibrosis based on small molecule transmembrane anion transporters 2016
26 GALAXY GALAXY: Gut-and-liver axis in alcoholic liver fibrosis 2016
27 MIRASYS The diagnostic potential of miRNAs for early diagnosis of Systemic Sclerosis 2016
28 Gene2Skin Gene2Skin - Roadmap for advanced genetic engineering-based skin therapies 2015
29 DeMILI NON INVASIVE DIAGNOSTIC TEST SERVICE FOR “NON ALCOHOLIC FATTY LIVER DISEASE” MANAGEMENT 2016
30 CollBioImag Development of a cell-based system for high-throughput screening of antifibrotics 2016
31 ENDYVE ENgineering DYnamic ViscoElasticity to study cell response 2016
32 PERICYTEStroma Pericyte-derived tumor stroma – a target for cancer therapy 2016
33 GENDER-CF Gender-related differences in expression of microRNAs in cystic fibrosis 2017
34 CureCKDHeart Targeting perivascular myofibroblast progenitors to treat cardiac fibrosis and heart failure in chronic kidney disease 2016
35 NANOZ-ONIC Bio-inspired electrONIC NOSE interfacing olfactory electrical biosensors and carbon NANOtubes 2016
36 CF_struct High-Resolution X-ray Structures of Full-Length Cystic Fibrosis Transmembrane Conductance Regulator 2016
37 Niche Fibrosis Identification of regulatory signals from vascular niche in alveolar regeneration and pulmonary fibrosis 2016
38 DMD2CURE Correction of duplications in the DMD gene by a CRISPR/Cas9 approach 2017
39 HepatoMetaboPath Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC 2016
40 Relieve-Chol Reprogramming cell identity to develop new therapies against Cholangiopathies 2016
41 RespeCT Respiratory Disease Screening with Dark-Field Computed Tomography 2016
42 Neurofibres Biofunctionalised Electroconducting Microfibres for the Treatment of Spinal Cord Injury 2017
43 SEMA3C Genetic dissection of the SEMA3C/Neuropilin 1 signalling pathway in Chronic Kidney Disease progression 2016
44 EXNADMINA EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease 2016
45 SWEETBULLETS Sweet Theranostics in Bitter Infections - Seek and Destroy 2017
46 MUC2GO THE ROLE OF MUCINS AND MUCUS IN THE DISEASES CYSTIC FIBROSIS, CELIAC DISEASE, AND ULCERATIVE COLITIS 2016
47 FiTTeR Developing a Fibrosis Targeting and Tissue Reparative (FiTTeR) Therapy for the Infarcted Myocardium via an Injectable Functionalized Extracellular Matrix Hydrogel 2017
48 Glyco-Platforms Novel smart glyco-nanomaterials as targeted therapeutics. 2017
49 CFZEBRA Balancing the immune response in cystic fibrosis: using zebrafish models of infection and inflammation to uncover new therapeutic approaches 2017
50 PRELICAN Treatment of liver disease and cancer prevention 2017
51 HEPASPHER Mimicking liver disease and regeneration in vitro for drug development and liver transplantation 2017
52 deFIBER Dissecting the cellular and molecular dynamics of bone marrow fibrosis for improved diagnostics and treatment 2018
53 LITMUS Liver Investigation: Testing Marker Utility in Steatohepatitis 2017
54 New Chol Development of New therapies against cholangiopathies. 2017
55 HIT-CF Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) 2018
56 OligoGpivotalCF A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis 2018
57 N-IF The N-IF mouse – a new and unique fibrosis model for preclinical efficacy studies 2017
58 IRONAGE Iron as a driver of fibrosis and regeneration 2018
59 ROCKSOFT Rho GTPase cross-talk with syndecan-4 regulates pro-fibrotic mechanotransduction in the heart 2019
60 CaLecLig Calcium-dependent Lectins in Human Pathogenic Infections: From Atomistic Understanding to Ligand Design 2018
61 EnCAge Progeria models to study endothelial cell ageing: implications for organ regeneration and fibrosis 2020
62 COAGULANT CK2-dependent cytoskeletal regulation and molecular signaling of Neutrophil Extracellular Trap (NET) formation 2018
63 FIBROSIS Fibroproliferative Invasive Fibroblasts in Idiopathic Pulmonary Fibrosis 2018
64 ASSYSt A reliable CXCL4 biomarker assay to improve diagnosis and treatment of Systemic Sclerosis 2018
65 LIFT Liquid Foam Therapy (LIFT) for Acute Respiratory Distress Syndrome (ARDS) 2018
66 FIBROHALT Advancing a novel peptide-based therapeutic for pancreatic cancer 2018
67 EPIORGABOLISM Diabetic nephropathy modelling in hESC-derived 3D kidney organoids 2019
68 TransReg Transgenerational epigenetic inheritance of cardiac regenerative capacity in the zebrafish 2019
69 ProMiDis A unified drug discovery platform for protein misfolding diseases 2019
70 HepEDOT Conductive, self-doping and biodegradable oligoEDOT-heparin biomaterial for improved electromechanical coupling, cardiac cell retention and delivery of paracrine factors 2019
71 DIE_CKD Deciphering intrarenal communication to unvail mechanisms of chronic kidney diseases 2019
72 TargetDUBs Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases 2019
73 RespiriNTM Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs 2019
74 MechanoGPER Development of GPER agonists as a novel therapeutic option for pancreatic cancer 2019
75 HEPCAN A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) 2019
76 CYPNASH Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis 2019
77 LIGHT4LUNGS Inhalable Aerosol Light Source for Controlling Drug-Resistant Bacterial Lung Infections 2019
78 POWER-PATCH Self-Powered Skin Patch for Cystic Fibrosis Diagnosis 2020
79 RheoCare Rheological Monitoring of Chronic Respiratory Diseases 2019
80 REMEDIA Impact of exposome on the course of lung diseases 2020
81 LiverScreen Screening for liver fibrosis - population-based study across European countries 2020
82 DRTB-HDT STRATIFIED HOST-DIRECTED THERAPY FOR DRUG-RESISTANT TUBERCULOSIS: A RANDOMIZED CONTROLLED MULTI-CENTRE TRIAL 2020
83 ICaRMuSs Intragranullar calcium regulation of mucin secretion and sorting. 2020
84 MRTFSen MRTF/SRF signalling in regulation of cell senescence and melanoma progression 2020
85 HTS MALDI-TOF MDD MALDI-TOF mass spectrometry metabolite screening assays for drug discovery in human disease 2020